World News
Esperion Therapeutics is being taken private by ARCHIMED in a $1.1 billion deal

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Shareholders will receive $3.16 per share in cash at closing — a 58% premium — plus contingent payments of up to $100 million


